KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Gilead Sciences (GILD) over the last 16 years, with Q3 2025 value amounting to $22.1 billion.

  • Gilead Sciences' Non-Current Debt rose 325.61% to $22.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 billion, marking a year-over-year increase of 325.61%. This contributed to the annual value of $24.9 billion for FY2024, which is 736.12% up from last year.
  • Per Gilead Sciences' latest filing, its Non-Current Debt stood at $22.1 billion for Q3 2025, which was up 325.61% from $22.1 billion recorded in Q2 2025.
  • Gilead Sciences' 5-year Non-Current Debt high stood at $27.9 billion for Q2 2021, and its period low was $21.2 billion during Q2 2023.
  • For the 5-year period, Gilead Sciences' Non-Current Debt averaged around $23.6 billion, with its median value being $23.0 billion (2022).
  • Its Non-Current Debt has fluctuated over the past 5 years, first soared by 3227.5% in 2021, then tumbled by 1582.06% in 2023.
  • Gilead Sciences' Non-Current Debt (Quarter) stood at $25.2 billion in 2021, then dropped by 8.82% to $23.0 billion in 2022, then increased by 1.01% to $23.2 billion in 2023, then increased by 7.36% to $24.9 billion in 2024, then decreased by 11.09% to $22.1 billion in 2025.
  • Its last three reported values are $22.1 billion in Q3 2025, $22.1 billion for Q2 2025, and $22.1 billion during Q1 2025.